SCHEMBL16058355

SCHEMBL16058355

Cc1c(-c2cccc(-c3ccccc3)c2)ccnc1OC(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PORCN Q9H237 1/20 0.41
▸ MAP3K8 P41279 2/20 0.38
▸ KMO O15229 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ MAP2K1 Q02750 1/20 0.38
▸ PTGER1 P34995 1/20 0.38
▸ PTGER4 P35408 1/20 0.38
▸ PTGER3 P43115 1/20 0.38
▸ PTGER2 P43116 1/20 0.38
▸ COMT P21964 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ EPHX1 P07099 1/20 0.37
▸ ABHD6 Q9BV23 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ PSEN1 P49768 1/20 0.36
▸ PSEN2 P49810 1/20 0.36
▸ APH1B Q8WW43 1/20 0.36
▸ NCSTN Q92542 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14975894 0.90 PORCN (0.40) PORCNMEN1RAB9AKMT2AEPHX1
SCHEMBL16057338 0.88 KMO (0.44) PORCNKMOMEN1RAB9AKMT2A
SCHEMBL16058375 0.86 PLA2G2A (0.41) ABHD6
SCHEMBL16057661 0.85 SLC2A1 (0.42) PORCNMEN1RAB9AKMT2AEPHX1
SCHEMBL16058727 0.83 PTGS1 (0.41) MEN1KMT2APSEN1PSEN2APH1B
SCHEMBL16056701 0.82 KMO (0.41) KMOMEN1RAB9AKMT2A
SCHEMBL16058493 0.82 SMN1; SMN2 (0.41) MAPK1MEN1RAB9AKMT2AWNT3A
SCHEMBL16057029 0.82 KDM5A (0.40) —
SCHEMBL16057423 0.81 CCNC (0.39) PORCNMEN1KMT2AEPHX1PIK3CA
SCHEMBL16057874 0.81 LDHA (0.43) SQORPDCD1CD274WNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828338-B2 Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-28 — — US disclosed
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-03-10 — — US disclosed
WO-2014144836-A2 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS NAAA, FAAH, FAAH2 PORCN 171/4885MAP3K8 2196/4885KMO 1677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback